| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.44 | 0.006 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.008 |